ICU Medical, Inc. engages in the development, manufacture, and sale of medical devices used in infusion therapy, oncology, and critical care applications. The company's product line includes custom infusion systems, closed delivery systems for hazardous drugs, needleless infusion connectors, catheters, and cardiac monitoring systems. Its products enhance patient outcomes by preventing bloodstream infections, protecting healthcare workers and patients from exposure to infectious diseases or hazardous drugs, and monitoring the cardiac output of critical care patients. The company offers intravenous (I.V.) therapy lines consisting of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein for use in hospitals and ambulatory clinics; and Clave product, a needleless I.V. connection device, which is used with conventional peripheral or central vascular access systems for venous and arterial applications. It also provides critical care products that monitor vital signs and specific physiological functions of key organ systems, including disposable pressure-sensing devices, minimally invasive monitoring sensors, angiography kits, and catheters for various purposes. In addition, the company provides a line of oncology products, Spiros male luer connector device, the Genie vial access device, custom infusion sets, and ancillary products designed for chemotherapy; and TEGO, a needle-free hemodialysis connector. ICU Medical, Inc. sells its products to medical product manufacturers and distributors. The company was founded in 1984 and is headquartered in San Clemente, California.